id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0195-0102,FDA,FDA-2013-N-0195,"Neurological Devices; Withdrawal of Proposed Effective Date of
Requirement for Premarket Approval for Cranial Electrotherapy Stimulator Devices",Proposed Rule,Withdrawal,2014-06-12T04:00:00Z,2014,6,2014-06-12T04:00:00Z,,2014-06-12T15:07:58Z,2014-13756,0,0,09000064817414fd
FDA-2013-N-0195-0100,FDA,FDA-2013-N-0195,"Effective Date of Requirement for Premarket Approval for
Transilluminator for Breast Evaluation and Sorbent Hemoperfusion System (SHS) Devices for the Treatment of Hepatic Coma and Metabolic
Disturbances; Reclassification of SHS Devices for the Treatment of Poisoning and Drug Overdose",Rule,Final Rule,2014-01-17T05:00:00Z,2014,1,2014-01-17T05:00:00Z,,2014-01-17T15:57:55Z,2014-00873,0,0,0900006481510c9a
FDA-2013-N-0195-0001,FDA,FDA-2013-N-0195,Effective Date of Requirement for Premarket Approval for Three Class III Preamendments Devices: Reclassification of Sorbent Hemoperfusion Devices for the Treatment of Poisoning and Drug Overdose,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2013-04-04T04:00:00Z,2013,4,2013-04-04T04:00:00Z,2013-05-07T03:59:59Z,2014-05-07T01:03:54Z,2013-07730,0,0,0900006481268b15